Allergy Diagnostics and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Diagnostics and Therapeutics), Allergen Type, Test Type, Product, Drug Class, End User, and Region (North America, Europe, Asia Pacific, Latin America, and

The allergy diagnostics and therapeutics market size is expected to reach USD 78.51 billion by 2034, according to a new study by Polaris Market Research. The report “Allergy Diagnostics and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Diagnostics and Therapeutics), Allergen Type, Test Type, Product, Drug Class, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Allergy dDiagnostics and tTherapeutics refer to the methods and treatments used to identify and manage allergic reactions in individuals. Allergy diagnostics involve a variety of tests to determine specific allergens that trigger allergic responses, such as skin prick tests, blood tests, and molecular diagnostics. These tests help healthcare providers pinpoint the cause of allergies, whether it be environmental factors, food, or other substances.

The allergy diagnostics and therapeutics market is experiencing a significant growth, driven by the increasing prevalence of allergies worldwide, including conditions such as asthma, rhinitis, and food allergies.

Key drivers include rising environmental pollution, urbanization, and lifestyle changes, which are contributing to higher allergy rates. Technological advancements in diagnostic tools, such as multiplex testing and molecular diagnostics, are enhancing accuracy and speed in identifying allergens. Opportunities lie in the growing demand for personalized treatments, including allergy immunotherapy, and expanding access to allergy management solutions in emerging markets.

Allergy Diagnostics and Therapeutics Market Report Highlights

The diagnostics segment dominates the market due to the increasing demand for accurate and efficient allergy testing methods, while the therapeutics segment is also registering the fastest growth, driven by the rising adoption of allergy immunotherapy treatments.

The food segment holds the largest allergy diagnostics and therapeutics market share, with a growing number of food allergies globally, while the inhaled segment is experiencing the fastest growth due to rising respiratory allergies fueled by environmental pollution and urbanization.

The in-vitro test segment leads the market due to the preference for non-invasive, highly accurate blood tests, while the in-vivo test segment is seeing the highest growth, particularly in clinical settings for faster, direct allergy diagnoses.

North America dominates the market, driven by advanced healthcare infrastructure and high allergy prevalence, while Asia Pacific is the fastest growing region, fueled by increasing allergy awareness, urbanization, and improving healthcare systems.

Polaris Market Research has segmented the allergy diagnostics and therapeutics market report based on type, allergen type, test type, product, drug class, end user, and region:

By Type Outlook (Revenue-USD Billion, 2020 – 2034)

Diagnostics

Therapeutics

By Allergen Type Outlook (Revenue-USD Billion, 2020 – 2034)

Food

Inhaled

Drug

Others

By Test Type Outlook (Revenue-USD Billion, 2020 – 2034)

In-vivo Test

In-vitro Test

By Product Outlook (Revenue-USD Billion, 2020 – 2034)

Consumables

Instruments

Services

By Drug Class Outlook (Revenue-USD Billion, 2020 – 2034)

Corticosteroids

Antihistamines

Leukotriene Inhibitors

Decongestants

Nasal Anticholinergics

Others

By End User Outlook (Revenue-USD Billion, 2020 – 2034)

Hospitals

Diagnostics Labs

Research & Development Centers

Others

By Regional Outlook (Revenue-USD Billion, 2020 – 2034)

North America

• US
• Canada

• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe

• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific

• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

• Mexico
• Brazil
• Argentina
• Rest of Latin America